MedPath

Multimodal analgesia study of nefopam combined with ketorolac, paracetamol and gabapentin compare to morphine in postoperative unilateral total knee arthroplasty ; a double blind, randomized clinical trial

Not Applicable
Conditions
pain in postoperative unilateral total knee arthroplasty patients
Pain
Total knee arthroplasty
multimodal analgesia
morphine
Registration Number
TCTR20201228004
Lead Sponsor
erdsin hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
100
Inclusion Criteria

1.Postoperative unilateral total knee arthroplasty patients.
2.Patients whose medial collateral ligament were not released
3.Underwent spinal block without morphine injection to subarachnoid space

Exclusion Criteria

1.Cannot give information about VAS
2.History of knee surgery same side of total knee arthroplasty
3.BMI equal or more than 40 kg/square meters
4.Underlying disease that are contraindicated to nefopam, ketorolac, paracetamol, gabapentin, morphine : chronic liver disease, cardiac or chronic renal failure(GFR < 90 ml/min/1.73m2), psychiatric disorder, alcohol abuse, glaucoma, peptic ulcer, inflammatory bowel disease, established, ischemic heart disease, suicidal idea
5.History of drug allergy to sulfonamides group
6.Allergy to aspirin, NSAIDs, selective COX-2 inhibitors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain score 2&#44;6&#44;12&#44;24 hours postoperative Visual analog scale
Secondary Outcome Measures
NameTimeMethod
Side effects and complications from multimodal analgesia and morphine 2&#44;6&#44;12&#44;24 hours postoperative ask for symptoms
© Copyright 2025. All Rights Reserved by MedPath